Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Nemera
Nemera
Activities:
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Drug Delivery
Cristalia products with Nemera’s reusable pen injector commercialised in Brazil
Cristalia’s human growth hormone will be administered with CRISPEN, a pen injector designed by Nemera
Manufacturing
Nemera extends manufacturing capabilities in North America
With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Manufacturing
Nemera's manufacturing facility inaugurated in Poland
The total area of the new site covers over 11,000 square metres including a 3,400 square metres clean room space
Finance
Nemera to build drug delivery device facility in Poland
The production plant is being built on an area of 5 hectares with dedicated expandable clean room space
Regulatory
Nemera updates branding and website
“We are thrilled to launch our new identity that re-unites our purpose of putting patients first and our commitment of being a holistic and agile partner”
Manufacturing
BIOMM to commercialise Nemera's reusable insulin pen
BIOMM will market the product under the trade name Lifepen in Brazil, where around 16.8 million people suffer from diabetes
Finance
Nemera to acquire Copernicus
The acquisition establishes Nemera’s operations footprint in Eastern Europe.
Subscribe now